These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 1532651)

  • 1. [Treatment with octreotide for functional obstructions in scleroderma].
    Emmerich J; Roux ME; Capron L; Fiessinger JN
    Presse Med; 1992 Feb; 21(7):316-7. PubMed ID: 1532651
    [No Abstract]   [Full Text] [Related]  

  • 2. Octreotide may prevent definitive intestinal obstruction.
    Mercadante S; Kargar J; Nicolosi G
    J Pain Symptom Manage; 1997 Jun; 13(6):352-5. PubMed ID: 9204656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colon stricture and volvulus in a patients with scleroderma.
    Haque U; Yardley J; Talamini M; Wigley F
    J Rheumatol; 1999 Oct; 26(10):2268-72. PubMed ID: 10529154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scleroderma with diverticulosis and colonic obstruction.
    Compton R
    Am J Surg; 1969 Oct; 118(4):602-6. PubMed ID: 5821702
    [No Abstract]   [Full Text] [Related]  

  • 5. Case report: volvulus of the splenic flexure in a patient with systemic sclerosis.
    Sanderson AJ; Elford J; Hayward SJ
    Br J Radiol; 1995 May; 68(809):537-9. PubMed ID: 7788244
    [No Abstract]   [Full Text] [Related]  

  • 6. Medical Therapy of Malignant Bowel Obstruction With Octreotide, Dexamethasone, and Metoclopramide.
    Berger J; Lester P; Rodrigues L
    Am J Hosp Palliat Care; 2016 May; 33(4):407-10. PubMed ID: 25646530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transverse colon volvulus associated with scleroderma.
    Budd DC; Nirdlinger EL; Sturtz DL; Fouty WJ
    Am J Surg; 1977 Mar; 133(3):370-2. PubMed ID: 848667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Octreotide treatment of chronic intestinal pseudoobstruction secondary to connective tissue diseases.
    Perlemuter G; Cacoub P; Chaussade S; Wechsler B; Couturier D; Piette JC
    Arthritis Rheum; 1999 Jul; 42(7):1545-9. PubMed ID: 10403284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Scopolamine butylbromide plus octreotide in unresponsive bowel obstruction.
    Mercadante S
    J Pain Symptom Manage; 1998 Nov; 16(5):278-80. PubMed ID: 9846021
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment with intravenous triiodothyronine of colonic pseudo-obstruction caused by myxoedema.
    Batalis T; Muers M; Royle GT
    Br J Surg; 1981 Jun; 68(6):439. PubMed ID: 7237075
    [No Abstract]   [Full Text] [Related]  

  • 11. Octreotide prevents the pathological alterations of bowel obstruction in cancer patients.
    Mercadante S; Avola G; Maddaloni S; Salamone G; Aragona F; Rodolico V
    Support Care Cancer; 1996 Sep; 4(5):393-4. PubMed ID: 8883235
    [No Abstract]   [Full Text] [Related]  

  • 12. Octreotide for malignant bowel obstruction: twenty years after.
    Mercadante S; Porzio G
    Crit Rev Oncol Hematol; 2012 Sep; 83(3):388-92. PubMed ID: 22277783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe intestinal pseudoobstruction in a patient with systemic sclerosis. Successful treatment with octreotide.
    Lanting PJ; Kruijsen MW; Rasher JJ; van den Hoogen FH; Boerbooms AM; van de Putte LB
    J Rheumatol; 1993 Dec; 20(12):2175. PubMed ID: 8014959
    [No Abstract]   [Full Text] [Related]  

  • 14. [The adjuvant chemotherapy of obstructive colonic cancer].
    Matviĭchuk BO
    Lik Sprava; 1998; (7):105-7. PubMed ID: 10050474
    [No Abstract]   [Full Text] [Related]  

  • 15. Transverse colon volvulus: a case report.
    Javors BR; Sorkin NS; Flint GW
    Am J Gastroenterol; 1986 Aug; 81(8):708-10. PubMed ID: 3740031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of treatment-related intermittent partial small bowel obstruction: the use of octreotide.
    Myers J; Tamber A; Farhadian M
    J Pain Symptom Manage; 2010 Apr; 39(4):e1-3. PubMed ID: 20153136
    [No Abstract]   [Full Text] [Related]  

  • 17. The use of octreotide in bowel obstruction.
    Mercadante S
    Palliat Med; 1993; 7(1):78. PubMed ID: 8287204
    [No Abstract]   [Full Text] [Related]  

  • 18. Why not octreotide?
    Mercadante S
    Support Care Cancer; 1994 May; 2(3):205-6. PubMed ID: 7913384
    [No Abstract]   [Full Text] [Related]  

  • 19. The role of octreotide in malignant bowel obstruction.
    Krammer LM
    Oncol Nurs Forum; 1999 Jun; 26(5):831-2. PubMed ID: 10382174
    [No Abstract]   [Full Text] [Related]  

  • 20. How to use octreotide for malignant bowel obstruction.
    Ripamonti C; Mercadante S
    J Support Oncol; 2004; 2(4):357-64. PubMed ID: 15357519
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.